Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-02-21

Clinical Trial Update: Impact of Vertebral Fracture Knowledge on Persistence in Subjects Taking Glucocorticoid Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing how knowledge of vertebral fractures influences persistence on glucocorticoid therapy in osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • glucocorticoids (glucocorticoids)

Snippet

Sponsor: Sanofi | Conditions: Osteoporosis | Phase 4 | Status: COMPLETED